Don’t miss this list of resources for University of Illinois Cancer Center trainees, everything from funding opportunities and conferences to training, webinars and workshops. Email the Cancer Center’s Cancer Research Training and Education Coordination (CRTEC) team at [email protected] for more information or assistance.
Funding Opportunities
- 2025 Harold M. Weintraub Graduate Student Award
- NEI Expand OHDSI Initiative for Eye Care and Ocular Imaging Challenge
- Data Science careers at NIH
- CCTS Pilot Grant Program
- Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed)
- Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
- Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) – Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
- Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
- NOITP: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
- NOITP: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
- Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute
- Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
- Notice of Special Interest (NOSI): Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control
- Mechanisms that impact Cancer Risk after Bariatric Surgery: PAR-25-043 (R01 Clinical Trial Optional) and PAR-25-044 (R21 Clinical Trial Not Allowed)
- Microbial-based Cancer Imaging and Therapy – Bugs as Drugs funding opportunities: R01 Clinical Trial Not Allowed (PAR-25-107) and R21 Clinical Trial Not Allowed (PAR-25-108)
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) (PA-25-172)
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) (PA-25-253)
- Co-infection and Cancer funding opportunities: R01 Clinical Trial Not Allowed (PAR-25-082) and R21 Clinical Trial Not Allowed (PAR-25-083)
- Cancer Prevention and Control Clinical Trials Planning Grant Program funding opportunities: U34 Clinical Trials Optional (PAR-25-103) and R34 Clinical Trials Optional (PAR-25-104)
- Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) (PAR-25-145)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) (PAR-25-221)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) (PAR-25-221)
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) (PAR-24-311)
- Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) (PAR-25-106)
- Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) (PAR-25-175)
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
- Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- Co-infection and Cancer (R01 Clinical Trial Not Allowed)
- Co-infection and Cancer (R21 Clinical Trial Not Allowed)
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
- Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
- Microbial-based Cancer Imaging and Therapy – Bugs as Drugs (R01 Clinical Trial Not Allowed)
- Microbial-based Cancer Imaging and Therapy – Bugs as Drugs (R21 Clinical Trial Not Allowed)
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
- Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
- Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
- Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
- Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
- Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
Conferences, Seminars, Webinars and Workshops
- Cancer Research Efforts Focused on Middle Eastern and North African Populations Residing in the United States: November 20, 2024
- A New Lens on Lunge Cancer: Infusing Lung Cancer Conversations with HIV Learnings: November 21, 2024
- Advanced Practice Providers’ Impact on Cancer Care Delivery: Bridging Research and Practice: November, 21, 2024
- NCI Rising Scholars: Cancer Research Seminar Series: November 20, 2024
- National Behavioral Health Network for Tobacco and Cancer Control: National Council for Mental Wellbeing: November 21, 2024
- 2025 Monica Baskin Diversity Institute for Emerging Leaders: December 3, 2024
- CARDS Webinar: Exploring US Neighborhood Level Cancer Risk Factor Datasets: December 4, 2024
- 2024 US Southwest Healthcare Innovation Summit: December 4, 2024
- ORBIT Institute: Developing Behavioral Treatments to Improve Health: December 6, 2024
- Equitable Access to Clinical Trials Webinar for Trial Site Staff: December 11, 2024
- 2025 Early Career Researcher Mentoring Program: December 12, 2024
- Mind Your BEAT: A Community-based Intervention to Increase Physical Activity and Reduce Psychosocial Distress in Rural Cancer Survivors: December 17, 2025
- NCI Workshop – In Vivo Engineering of Immune Cells for Cancer Immunotherapy: January 28-29, 2025
- University of California, Davis Comprehensive Online Course in Flow Cytometry: February 3-7, 2025
- Cold Spring Harbor Laboratory Innovators Symposium: February 24-26, 2025
- 2025 Sexual & Gender Minority Cancer CARE Workshop: February 26 – March 1, 2025
- NCI Symposium on Translational Technologies for Global Health: March 19-20, 2025
- 2025 NCI RNA Biology Symposium: April 3-4, 2025
- Chicago K Day 2025: February 6, 2025
- AACR Annual Meeting 2025: Submit an Abstract: April 25-30, 2025
- NCI Workshop: Transformative Microsystem Technologies for Cancer Diagnostics, Management, and Treatment Response: February 5-6, 2024
- Consortium for Implementation Science (CCIS): February 26-28, 2025
- Announcing a New Toolkit to Support Health Systems Utilizing the National Standards for Cancer Survivorship Care
- 2023 Behavioral Risk Factor Surveillance System Dataset and Tools
- ASPO’s 2025 Annual Meeting Seeking Volunteer Co-Chairs
- Interdisciplinary Network for Survivorship and Primary Care Research: March 3, 2025
- Duke Cancer Institute Invited Scholar Research Symposium: March 20-21, 2025
- Precision Integrative Medicine for Cancer Survivors: January 14, 2025
- 13th Annual Symposium on Global Cancer Research: May 5-8, 2025
- Cancer AI Conversation: Evaluating AI Models – Benchmarking and Fairness: November 26, 2024
- Studying the Context and Complexity of Oncogenes and Oncogene Addiction Paradigms in MalignanciEs (SCOPE) Think Tank: December 9-10, 2024
- AI in IO: SITC-NCI Computational Immuno-Oncology Webinar – Increasing Awareness and Addressing Disparities with Fairness AIExit Disclaimer: December 17, 2024
- DCB New Grantee Workshop: January 9-10, 2025
- Nature Webinar – The Human Tumor Atlas Network (HTAN): Exploring Tumor Evolution in Time and SpaceExit Disclaimer: January 14, 2025
Training Programs and Internships
- National Cancer Institutes’ (NCI) Intramural Continuing Umbrella Experiences (iCURE)
- 2025 Summer Undergraduate Research Fellowship (SURF) at Mayo Clinic
- T32 Postdoctoral Training in Behavioral Oncology
- Postdoctoral Positions Cancer Population Science Georgetown University Lombardi Comprehensive Cancer Center
- UIC Cancer Health Equity and Career Development Program for Pre/Post-Docs
- Fanconi Cancer Foundation- AACR NextGen Grant for Transformative Cancer Research
- Robert A Winn Diversity in Clinical Trials Award Program
- NCI Cancer Prevention Fellowship Program
- AACR-AstraZeneca Breast Cancer Research Fellowship for Endocrine Therapy Research
- OSUCCC Cancer Prevention and Cancer Control T32 postdoctoral Training Grant
- Postdoctoral Fellow – Centrosome, microscopy, cancer
- Postdoctoral Fellow – Redox Biology, DNA damage response
- Beginning Investigator Grant for Catalytic Research: December 6, 2024
- 2025 Systems Approaches to Cancer Biology Scholars: December 2, 2025
More Trainee Resources
Email the Cancer Center’s Cancer Research Training and Education Coordination (CRTEC) team at [email protected].